The result showed that 60% (6/10) of pulmonary NMC had somatic nonsynonymous mutation in PI3K/AKT pathway, including PTEN, PIK3R1, PIK3CA, ERBB4, and RPTOR (Figure 4B). Here, AKT1 is linked to nut midline carcinoma.